It has also been suggested that TNF–A20 signaling axis is responsible for TNF-mediated IL-17 inhibition in CD4+ T cells, which is related to disease exacerbation in inflammatory bowel diseases and multiple sclerosis in addition to paradoxical reactions in psoriasis as a response to anti-TNF therapies (123). The gene discussed is TNF; the disease is psoriasis.